Ost-müük Catalent Inc - CTLT CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | 0.32 | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.024068% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.001846% | ||||||||
Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | USD | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United States of America | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Catalent Inc ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Eelmine sulgemine* | 65.78 |
Avatud* | 66.18 |
Aastane muutus* | -38.6% |
Päeva ulatus* | 65.83 - 66.74 |
52 nädala ulatus | 40.69-115.34 |
Keskmine maht (10 päeva) | 1.78M |
Keskmine maht (3 kuud) | 49.42M |
Turukapitalisatsioon | 11.87B |
P/E suhtarv | 29.17 |
Ringluses olevad aktsiad | 180.09M |
Tulu | 4.76B |
EPS | 2.26 |
Dividendid (% kasumist) | N/A |
Beeta | 1.19 |
Järgmine tuluaruande kuupäev | May 1, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|---|---|---|---|---|---|
Mar 29, 2023 | 66.74 | 0.83 | 1.26% | 65.91 | 66.93 | 65.73 |
Mar 28, 2023 | 65.78 | -0.76 | -1.14% | 66.54 | 66.61 | 65.26 |
Mar 27, 2023 | 67.34 | 3.07 | 4.78% | 64.27 | 68.59 | 64.21 |
Mar 24, 2023 | 64.11 | 2.46 | 3.99% | 61.65 | 64.24 | 60.69 |
Mar 23, 2023 | 62.47 | -2.06 | -3.19% | 64.53 | 64.78 | 62.07 |
Mar 22, 2023 | 64.46 | -1.90 | -2.86% | 66.36 | 66.82 | 64.42 |
Mar 21, 2023 | 66.60 | -0.48 | -0.72% | 67.08 | 68.56 | 66.48 |
Mar 20, 2023 | 66.79 | 0.48 | 0.72% | 66.31 | 67.69 | 64.72 |
Mar 17, 2023 | 66.94 | -2.06 | -2.99% | 69.00 | 69.00 | 66.40 |
Mar 16, 2023 | 70.99 | 2.17 | 3.15% | 68.82 | 71.13 | 68.02 |
Mar 15, 2023 | 69.66 | 0.97 | 1.41% | 68.69 | 70.06 | 67.23 |
Mar 14, 2023 | 70.15 | 3.76 | 5.66% | 66.39 | 71.17 | 66.39 |
Mar 13, 2023 | 65.49 | -1.33 | -1.99% | 66.82 | 66.83 | 64.00 |
Mar 10, 2023 | 67.75 | -1.43 | -2.07% | 69.18 | 69.43 | 66.78 |
Mar 9, 2023 | 69.74 | 0.53 | 0.77% | 69.21 | 71.92 | 69.15 |
Mar 8, 2023 | 69.60 | 2.45 | 3.65% | 67.15 | 70.27 | 67.11 |
Mar 7, 2023 | 67.65 | -3.06 | -4.33% | 70.71 | 71.58 | 67.46 |
Mar 6, 2023 | 71.18 | -2.63 | -3.56% | 73.81 | 73.82 | 71.18 |
Mar 3, 2023 | 74.02 | 3.09 | 4.36% | 70.93 | 74.32 | 70.44 |
Mar 2, 2023 | 71.05 | 3.38 | 4.99% | 67.67 | 71.09 | 67.37 |
Catalent Inc Events
Kellaaeg (UTC) (UTC) | Riik | Sündmus |
---|---|---|
No events scheduled |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kogutulu | 4828 | 3998 | 3094.3 | 2518 | 2463.4 |
Tulu | 4828 | 3998 | 3094.3 | 2518 | 2463.4 |
Kulud, Kokku | 3188 | 2646 | 2111 | 1712.9 | 1710.8 |
Brutokasum | 1640 | 1352 | 983.3 | 805.1 | 752.6 |
Kogu tegevuskulu | 4076 | 3188 | 2716.2 | 2259.9 | 2204.1 |
Müük/Üldine/admin kulud, kokku | 844 | 687 | 575.3 | 508.7 | 456.3 |
Uuringud ja arendus | 2.6 | 3.3 | 6.3 | ||
Ootamatud kulutused (tulu) | 3 | -164 | 27.3 | 35 | 30.7 |
Tulud majandustegevusest | 752 | 810 | 378.1 | 258.1 | 259.3 |
Intressitulud (kulu), muud tulud, neto | -156 | -115 | -123.1 | -110.4 | -106.8 |
Muud, neto | 9 | 20 | 5.4 | 12.6 | -0.5 |
Netotulu enne makse | 605 | 715 | 260.4 | 160.3 | 152 |
Netotulu pärast makse | 519 | 585 | 220.7 | 137.4 | 126.2 |
Vähemuse intress | 0 | ||||
Netotulu enne erikulusid | 519 | 585 | 220.7 | 137.4 | 126.2 |
Erakorralised kulud kokku | -42.6 | ||||
Netotulu | 519 | 585 | 220.7 | 137.4 | 83.6 |
Arvestatav tulu, v a erikulud | 503 | 529 | 173 | 137.4 | 126.2 |
Arvestatav tulu, koos erikuludega | 503 | 529 | 173 | 137.4 | 83.6 |
Jaotamisele kuuluv netotulu | 503 | 529 | 173 | 137.4 | 83.6 |
Keskmine jaotamisele kuuluv aktsia kohta | 178 | 170 | 152.322 | 145.954 | 133.201 |
Jaotatav EPS, v a erakorralised kulud | 2.82584 | 3.11176 | 1.13575 | 0.94139 | 0.94744 |
Dividends per Share - Common Stock Primary Issue | |||||
Jaotamisele kuuluv normaal-EPS | 3.0379 | 2.4139 | 1.28765 | 1.14693 | 1.1388 |
Total Adjustments to Net Income | -16 | -56 | -47.7 | ||
Other Operating Expenses, Total | 41 | 19 |
Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | |
---|---|---|---|---|---|
Kogutulu | 1313 | 1273 | 1217 | 1025 | 1188.2 |
Tulu | 1313 | 1273 | 1217 | 1025 | 1188.2 |
Kulud, Kokku | 825 | 850 | 812 | 701 | 748.9 |
Brutokasum | 488 | 423 | 405 | 324 | 439.3 |
Kogu tegevuskulu | 1067 | 1062 | 1056 | 891 | 937.7 |
Müük/Üldine/admin kulud, kokku | 226 | 207 | 228 | 183 | 184.1 |
Ootamatud kulutused (tulu) | 0 | 0 | 0 | 3 | 2.8 |
Tulud majandustegevusest | 246 | 211 | 161 | 134 | 250.5 |
Intressitulud (kulu), muud tulud, neto | -37 | -37 | -47 | -35 | -30.8 |
Muud, neto | 2 | 2 | 1 | 4 | 1.8 |
Netotulu enne makse | 211 | 176 | 115 | 103 | 221.5 |
Netotulu pärast makse | 188 | 141 | 97 | 93 | 182.4 |
Netotulu enne erikulusid | 188 | 141 | 97 | 93 | 182.4 |
Netotulu | 188 | 141 | 97 | 93 | 182.4 |
Total Adjustments to Net Income | -1 | 0 | -4 | -9 | -13.5 |
Arvestatav tulu, v a erikulud | 187 | 141 | 93 | 84 | 168.9 |
Arvestatav tulu, koos erikuludega | 187 | 141 | 93 | 84 | 168.9 |
Jaotamisele kuuluv netotulu | 187 | 141 | 93 | 84 | 168.9 |
Keskmine jaotamisele kuuluv aktsia kohta | 181 | 181 | 177 | 172 | 171.5 |
Jaotatav EPS, v a erakorralised kulud | 1.03315 | 0.77901 | 0.52542 | 0.48837 | 0.98484 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
Jaotamisele kuuluv normaal-EPS | 1.10699 | 0.80114 | 0.60644 | 0.52512 | 1.00741 |
Other Operating Expenses, Total | 16 | 5 | 16 | 4 | 1.9 |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Käibevarad kokku | 2918 | 2293 | 1395.8 | 1240.3 | 1059.8 |
Raha ja lühiajalised investeeringud | 967 | 953.2 | 345.4 | 410.2 | 306.9 |
Raha ja ekvivalendid | 896 | 953.2 | 345.4 | 410.2 | 288.3 |
Laekumata arved, neto | 1193 | 899.5 | 716.4 | 555.8 | 488.8 |
Accounts Receivable - Trade, Net | 1193 | 899.5 | 716.4 | 555.8 | 488.8 |
Total Inventory | 593 | 346.9 | 265.3 | 220.2 | 196.7 |
Prepaid Expenses | 118 | 62.6 | 45.1 | 38.9 | 23.8 |
Other Current Assets, Total | 47 | 30.8 | 23.6 | 15.2 | 43.6 |
Total Assets | 9112 | 7776.5 | 6184 | 4531.1 | 3454.3 |
Property/Plant/Equipment, Total - Net | 2608 | 2002.2 | 1536.7 | 1270.6 | 995.9 |
Property/Plant/Equipment, Total - Gross | 3787 | 3046.8 | 2450.1 | 2097.9 | 1707.7 |
Accumulated Depreciation, Total | -1179 | -1044.6 | -913.4 | -827.3 | -711.8 |
Goodwill, Net | 2519 | 2470.6 | 2220.9 | 1397.2 | 1044.1 |
Intangibles, Net | 817 | 888.7 | 930.8 | 544.9 | 273.1 |
Other Long Term Assets, Total | 250 | 122 | 99.8 | 78.1 | 81.4 |
Total Current Liabilities | 1196 | 893.2 | 670.7 | 576.9 | 469 |
Accounts Payable | 385 | 321 | 255.8 | 192.1 | 163.2 |
Accrued Expenses | 401 | 303.8 | 174.7 | 186.1 | 171.6 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 75 | 72.9 | 76.5 | 71.9 | 24.6 |
Other Current Liabilities, Total | 335 | 195.5 | 163.7 | 126.8 | 109.6 |
Total Liabilities | 4838 | 4271.1 | 3895.8 | 3444.4 | 2730.8 |
Total Long Term Debt | 3166 | 2945.1 | 2882.8 | 2649.4 | 2055.1 |
Long Term Debt | 2988 | 2816.7 | 2882.8 | 2649.4 | 2055.1 |
Deferred Income Tax | 164 | 94 | 74.4 | 32.5 | 31.7 |
Minority Interest | |||||
Other Liabilities, Total | 312 | 338.8 | 267.9 | 185.6 | 175 |
Total Equity | 4274 | 3505.4 | 2288.2 | 1086.7 | 723.5 |
Common Stock | 2 | 1.6 | 1.5 | 1.3 | 1.3 |
Additional Paid-In Capital | 4205 | 3818.7 | 2757.4 | 2283.3 | 1992 |
Retained Earnings (Accumulated Deficit) | 25 | -535.2 | -723.4 | -872.1 | -955.7 |
Other Equity, Total | -316 | -385.2 | -304.8 | -324.7 | -324.6 |
Total Liabilities & Shareholders’ Equity | 9112 | 7776.5 | 6184 | 4531.1 | 3454.3 |
Total Common Shares Outstanding | 170.5 | 162.8 | 145.7 | 133.424 | 125.05 |
Lühiajalised investeeringud | 71 | 0 | 18.6 | ||
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Unrealized Gain (Loss) | -1 | -1.1 | -49.1 | -1.1 | 10.5 |
Redeemable Preferred Stock | 359 | 606.6 | 606.6 | ||
Total Preferred Shares Outstanding | 0.38478 | 0.65 | 0.65 | ||
Capital Lease Obligations | 178 | 128.4 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Käibevarad kokku | 3025 | 2974 | 3931 | 2918 | 2774.5 |
Raha ja lühiajalised investeeringud | 880 | 915 | 2019 | 967 | 1062.8 |
Raha ja ekvivalendid | 786 | 849 | 1969 | 896 | 988.1 |
Lühiajalised investeeringud | 94 | 66 | 50 | 71 | 74.7 |
Laekumata arved, neto | 1259 | 1179 | 1055 | 1193 | 1012.3 |
Accounts Receivable - Trade, Net | 1259 | 1179 | 1055 | 1193 | 1012.3 |
Total Inventory | 697 | 709 | 653 | 593 | 555.1 |
Prepaid Expenses | 133 | 110 | 151 | 118 | 107.2 |
Other Current Assets, Total | 56 | 61 | 53 | 47 | 37.1 |
Total Assets | 10322 | 10203 | 10183 | 9112 | 8769.1 |
Property/Plant/Equipment, Total - Net | 2820 | 2727 | 2581 | 2608 | 2358.8 |
Property/Plant/Equipment, Total - Gross | 4128 | 3982 | 3796 | 3787 | 3480.4 |
Accumulated Depreciation, Total | -1308 | -1255 | -1215 | -1179 | -1121.6 |
Goodwill, Net | 3012 | 3026 | 2531 | 2519 | 2515 |
Intangibles, Net | 1097 | 1132 | 793 | 817 | 834.8 |
Other Long Term Assets, Total | 368 | 344 | 347 | 250 | 286 |
Total Current Liabilities | 1046 | 1045 | 1096 | 1196 | 1139.2 |
Accounts Payable | 401 | 363 | 363 | 385 | 365.7 |
Accrued Expenses | 390 | 362 | 346 | 401 | 351 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 29 | 29 | 79 | 75 | 73.6 |
Other Current Liabilities, Total | 226 | 291 | 308 | 335 | 348.9 |
Total Liabilities | 5690 | 5722 | 5803 | 4838 | 4696.9 |
Total Long Term Debt | 4157 | 4191 | 4225 | 3166 | 3149.6 |
Long Term Debt | 4157 | 4191 | 4225 | 2988 | 3149.6 |
Deferred Income Tax | 211 | 189 | 171 | 164 | 100.3 |
Other Liabilities, Total | 276 | 297 | 311 | 312 | 307.8 |
Total Equity | 4632 | 4481 | 4380 | 4274 | 4072.2 |
Redeemable Preferred Stock | 0 | 0 | 359 | 359 | 359 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Common Stock | 2 | 2 | 2 | 2 | 1.7 |
Additional Paid-In Capital | 4630 | 4615 | 4234 | 4205 | 4185.7 |
Retained Earnings (Accumulated Deficit) | 350 | 209 | 114 | 25 | -150.3 |
Unrealized Gain (Loss) | -3 | -2 | -1 | -1 | -1.1 |
Other Equity, Total | -347 | -343 | -328 | -316 | -322.8 |
Total Liabilities & Shareholders’ Equity | 10322 | 10203 | 10183 | 9112 | 8769.1 |
Total Common Shares Outstanding | 179 | 179 | 171 | 170.5 | 170.133 |
Total Preferred Shares Outstanding | 0 | 0 | 0 | 0.38478 | 0.38478 |
Capital Lease Obligations | 178 |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Netotulu/algväärtus | 585 | 220.7 | 137.4 | 83.6 | 109.8 |
Raha majandustegevusest | 433 | 440.3 | 247.7 | 374.5 | 299.5 |
Raha majandustegevusest | 289 | 253.7 | 228.6 | 190.1 | 146.5 |
Deferred Taxes | 64 | 2.4 | -15.1 | 35.4 | -1.3 |
Mittelikviidsed varad | -73 | 84.8 | 57.1 | 56.6 | 56.3 |
Cash Taxes Paid | 47 | 43.4 | 42.2 | 23.9 | 39.8 |
Makstud intressid | 105 | 98.4 | 102.5 | 83.2 | 80.8 |
Muutused tööjõus | -432 | -121.3 | -160.3 | 8.8 | -11.8 |
Tulu investeeringutelt | -649 | -827.5 | -1510.4 | -919.3 | -309 |
Kapitalikulutused | -686 | -465.8 | -218.1 | -176.5 | -139.8 |
Muud rahavood investeeringutelt, kokku | 37 | -361.7 | -1292.3 | -742.8 | -169.2 |
Rahavood investeeringutelt | 142 | 1001.7 | 1201.4 | 669.1 | 161.3 |
Rahavoogudesse investeerimine | -55 | -56.9 | -39.3 | -29.3 | -11.8 |
Aktsiate emiteerimine (tagasiost), neto | 120 | 1046.5 | 1091.8 | 277.8 | 0 |
Laenu väljastamine (kustutamine), neto | 99 | 48.3 | 148.9 | 420.6 | 173.1 |
Muutused valuutakursside kõikumisest | 17 | -6.7 | -3.5 | -2.4 | 4.9 |
Rahaline kogumuutus | -57 | 607.8 | -64.8 | 121.9 | 156.7 |
Total Cash Dividends Paid | -22 | -36.2 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 331 | 190 | 93 | 585 | 402.6 |
Cash From Operating Activities | 370 | 232 | 163 | 433 | 298.7 |
Cash From Operating Activities | 278 | 179 | 81 | 289 | 216 |
Deferred Taxes | 13 | 1 | -8 | 64 | 17.8 |
Non-Cash Items | 108 | 90 | 46 | -73 | -94.3 |
Cash Taxes Paid | 40 | 27 | 15 | 47 | 24.8 |
Cash Interest Paid | 93 | 50 | 40 | 105 | 97 |
Changes in Working Capital | -360 | -228 | -49 | -432 | -243.4 |
Cash From Investing Activities | -1490 | -1299 | -167 | -649 | -435.9 |
Capital Expenditures | -425 | -277 | -154 | -686 | -497.1 |
Other Investing Cash Flow Items, Total | -1065 | -1022 | -13 | 37 | 61.2 |
Cash From Financing Activities | 1030 | 1033 | 1082 | 142 | 159.3 |
Financing Cash Flow Items | -15 | -18 | -15 | -55 | -40.3 |
Total Cash Dividends Paid | -4 | -4 | -4 | -22 | -17.7 |
Issuance (Retirement) of Stock, Net | 21 | 19 | 8 | 120 | 103.9 |
Issuance (Retirement) of Debt, Net | 1028 | 1036 | 1093 | 99 | 113.4 |
Foreign Exchange Effects | -20 | -13 | -5 | 17 | 12.8 |
Net Change in Cash | -110 | -47 | 1073 | -57 | 34.9 |
Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 10.8322 | 19507768 | 361371 | 2022-12-31 | LOW |
T. Rowe Price Investment Management, Inc. | Investment Advisor | 9.2059 | 16578946 | -1841410 | 2022-12-31 | MED |
Capital World Investors | Investment Advisor | 7.6724 | 13817203 | 2407795 | 2022-12-31 | LOW |
Veritas Asset Management LLP | Investment Advisor/Hedge Fund | 6.2023 | 11169815 | 4212040 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.0028 | 9009519 | -53248 | 2022-12-31 | LOW |
Janus Henderson Investors | Investment Advisor/Hedge Fund | 4.5623 | 8216242 | 1402351 | 2022-12-31 | LOW |
Artisan Partners Limited Partnership | Investment Advisor | 4.3546 | 7842308 | 1973505 | 2022-12-31 | LOW |
Capital Research Global Investors | Investment Advisor | 4.3601 | 7813960 | 7813960 | 2022-06-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.0909 | 7367321 | 240521 | 2022-12-31 | LOW |
Leonard Green & Partners, L.P. | Private Equity | 2.4113 | 4342441 | 4149 | 2022-12-31 | LOW |
American Century Investment Management, Inc. | Investment Advisor/Hedge Fund | 2.3003 | 4142585 | 1051160 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 2.0146 | 3628169 | 121525 | 2022-12-31 | LOW |
Franklin Advisers, Inc. | Investment Advisor/Hedge Fund | 1.8274 | 3290989 | -2354982 | 2022-12-31 | LOW |
EARNEST Partners, LLC | Investment Advisor/Hedge Fund | 1.491 | 2685136 | 445745 | 2022-12-31 | LOW |
Eminence Capital, LP | Hedge Fund | 1.4145 | 2547332 | 1533669 | 2022-12-31 | MED |
Invesco Capital Management LLC | Investment Advisor | 1.0565 | 1902628 | 1042669 | 2022-12-31 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 1.0125 | 1823502 | 122451 | 2022-12-31 | LOW |
Novo Holdings A/S | Venture Capital | 0.9067 | 1632878 | 0 | 2022-12-31 | LOW |
Invesco Advisers, Inc. | Investment Advisor | 0.9044 | 1628683 | 176146 | 2022-12-31 | LOW |
Champlain Investment Partners, LLC | Investment Advisor | 0.8122 | 1462665 | 4170 | 2022-12-31 | LOW |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group500K+
Kauplejad
92K+
Igakuiste aktiivsete klientide arv
$53M+
Igakuine investeerimise maht
$30M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Catalent Company profile
Ettevõttest Catalent Inc
Catalent, Inc. pakub ravimite, valgu-, raku- ja geeniteraapia biotehnoloogiate ning tervishoiutoodete väljatöötamise ja tootmise lahendusi. Ettevõtte segmentide hulka kuuluvad Softgel ja Oral Technologies, Biologics, Oral and Specialty Delivery ja Clinical Supply Services. Softgel- ja suukaudsete tehnoloogiate segment tegeleb pehmete kapslite formuleerimise, arendamise ja tootmisega ning suukaudsete tahkete ravimvormide laiaulatusliku tootmisega. Bioloogiliste ravimite segment pakub bioloogiliste rakuliinide, rakuteraapia ja viirusvektorite geeniteraapia arendus- ja tootmisteenuseid. Oral and Specialty Delivery segment pakub preparaatide väljatöötamist ja tootmist mitmesuguste tehnoloogiate puhul koos integreeritud kliinilise arenduse ja kaubandusliku tarnimise lahendustega. Kliiniliste tarneteenuste segment tegeleb ravimite ja bioloogiliste ravimite tootmise, pakendamise, jaotamise ja varude haldamisega kliinilistes uuringutes.
Industry: | Pharmaceuticals (NEC) |
14 Schoolhouse Rd
SOMERSET
NEW JERSEY 08873-1213
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 500,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com